Elsevier Inc.

SHERPA: Unknown

People

  1. Abu-Rustum
    Abu-Rustum
  2. Chi
    Chi
  3. Lee
    Lee
  4. Giralt
    Giralt
  5. Mulhall
    Mulhall
  6. Perales
    Perales
  7. Sonoda
    Sonoda
  8. Leitao
    Leitao
  9. Yorke
    Yorke
  10. Wu
    Wu

Groups

  1. Department of Medicine (4613)
  2. Surgery (3547)
  3. Survivorship Research (2658)
  4. Solid Tumor Oncology Division (2652)
  5. Radiation Oncology, Department of (2124)
  6. GSK Faculty (1936)
  7. Center for Hematologic Malignancies (1672)
  8. Hematologic Malignancies, Division of (1609)
  9. Gynecology Disease Management Team (1426)
  10. Sloan Kettering Institute Faculty (1398)
Search Within
Formats
  1. Journal Article (7394)
  2. Meeting Abstract (4692)
  3. Review (620)
  4. Book Section (538)
  5. Editorial (251)
  6. Conference Paper (140)
  7. Correspondence (92)
  8. Guidelines (82)
  9. Research Letter (29)
  10. Miscellaneous (15)
  11. Book Whole (14)
Groups
  1. Department of Medicine (4613)
  2. Surgery (3547)
  3. Survivorship Research (2658)
  4. Solid Tumor Oncology Division (2652)
  5. Radiation Oncology, Department of (2124)
  6. GSK Faculty (1936)

More Groups

People
  1. Nadeem Abu-Rustum (464)
  2. Dennis Chi (420)
  3. Nancy Lee (409)
  4. Michael Zelefsky (401)
  5. Sergio Giralt (384)
  6. John Mulhall (377)

More People

Years
  1. 2025 (263)
  2. 2024 (784)
  3. 2023 (760)
  4. 2022 (794)
  5. 2021 (723)
  6. 2020 (714)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (2614)
  2. Gynecologic Oncology (1197)
  3. Journal of Thoracic Oncology (970)
  4. Biology of Blood and Marrow Transplantation (815)
  5. European Journal of Cancer (525)
  6. Journal of Sexual Medicine (435)

More Publications

Results (13867)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oh, the places you will go? Exploring the geographic program distribution and use of geographic preferences in the radiation oncology residency application cycle
    Editorial

    Mahoney, M. T.; Flores, L. E.; Alanis, A.; Qian, J. Y.; Bergman, D. T.; Chen, J. J.; Weiss, S. E.; Gunther, J. R.; Price, J. G.
    Advances in Radiation Oncology (2025)

    Fulltext@MSK | Save
  • Risk factors associated with sub-optimal outcomes and hematotoxicity following obecabtagene autoleucel (obe-cel) for relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL)
    Meeting Abstract

    Sandhu, K. S.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Abedi, M.; Shah, B.; Bishop, M. R.; Deangelo, D. J.; Brugger, W.; Shang, J.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • CAR and ALL hematotox scores predict toxicity and outcomes among recipients of brexucabtagene autoleucel for R/R ALL in the real world outcomes collaborative of CAR-T in adult ALL (ROCCA) consortium
    Meeting Abstract

    Valtis, Y.; Lin, C. Y.; Nemirovsky, D.; Devlin, S.; Rejeski, K.; Shah, N. N.; Nair, M. S.; Jeyakumar, N.; Miller, K.; Zhang, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Enhancing the persistence and anti-tumor efficacy of CAR-T and CAR-NK cells through genetic disruption of death receptors
    Meeting Abstract

    Cohen, T. D.; Yi, F.; Zumbo, P.; Etilib, R.; Arkin, H.; Gormally, M.; Hackett, C. S.; Kropp, K.; Etxeberria, I.; Chandran, S. S.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of a single-center cohort of renal cell carcinoma patients with KRAS mutation
    Meeting Abstract

    Sanmiguel, A. L.; Hakimi, A. A.; Khandwala, Y.; Calderon, L. P.; Dawidek, M.; Chen, Y. B.; Russo, P.; Coleman, J.; Carlo, M.
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Correlative science from a phase I study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
    Meeting Abstract

    Bochner, B. H.; Alam, S. M.; Blanchard, L.; Yao, N.; Angulo-Lozano, J.; Wong, J.; Knorr, D.; Whiting, K.; Seshan, V.; Donahue, T.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • A phase 1B trial of masofaniten (EPI-7386) in patients with metastatic castration-resistant prostate cancer (MCRPC)
    Meeting Abstract

    Laccetti, A.; Iannotti, N.; Pachynski, R.; Carthon, B.; Chi, K. N.; Smith, M.; Saad, F.; Pili, R.; Tu, W.; Kwan, E. M.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Transcriptional analysis of bladder cancer histologic subtypes reveals novel drug target heterogeneity
    Meeting Abstract

    Tallman, J. E.; Kuo, F.; Koll, F.; Alam, S. M.; Basar, M.; Luo, J.; Gao, S. P.; Tang, X.; Yol, C.; Gokturk, G.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Defining the optimal dose for 3-dimensional conformal accelerated partial breast irradiation: 15-year follow-up of a dose-escalation trial
    Journal Article

    Taghian, A. G.; Naoum, G. E.; Braunstein, L. Z.; Niemierko, A.; Smith, B. L.; Gadd, M. A.; Powell, S. N.; Recht, A.
    International Journal of Radiation Oncology, Biology, Physics (2025)

    Fulltext@MSK | Save
  • Current approaches to radiation oncology target volume delineation using PET/ computed tomography
    Review

    McMillan, M. T.; Feigenberg, S. J.; Simone, C. B. 2nd
    PET Clinics (2025)

    Fulltext@MSK | Save